Assessment of acitretin-treated female patients of childbearing age and subsequent risk of teratogenicity

Br J Dermatol. 2001 Dec;145(6):1028-9. doi: 10.1046/j.1365-2133.2001.04424.x.
No abstract available

Publication types

  • Clinical Trial
  • Comment
  • Letter

MeSH terms

  • Acitretin / pharmacokinetics*
  • Adult
  • Biotransformation / drug effects
  • Ethanol / pharmacology
  • Etretinate / analysis
  • Female
  • Humans
  • Keratolytic Agents / pharmacokinetics*
  • Psoriasis / drug therapy*

Substances

  • Keratolytic Agents
  • Ethanol
  • Etretinate
  • Acitretin